Download Supplemental Table 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cardiovascular disease wikipedia , lookup

Heart failure wikipedia , lookup

History of invasive and interventional cardiology wikipedia , lookup

Drug-eluting stent wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Remote ischemic conditioning wikipedia , lookup

Cardiac surgery wikipedia , lookup

Electrocardiography wikipedia , lookup

Angina wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Jatene procedure wikipedia , lookup

Atrial fibrillation wikipedia , lookup

Coronary artery disease wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Transcript
Supplemental Table 1. Serious cardiac outcome definitions. a
Outcome
Death
Myocardial Infarction (MI)
Heart Failure (HF)
Serious Arrhythmia
Refractory Ischemic Cardiac Pain
a
Definition
either cardiovascular or noncardiovascular
indicated by biochemical markers of
myocardial necrosis (e.g., a typical rise and
gradual fall of cTnI concentrations), along
with at least 1 of the following: ischemic
symptoms, development of pathologic Q
waves on the electrocardiogram or changes
indicative of ischemia, coronary artery
intervention, or pathologic findings of an
acute MI
as indicated by any 2 of these 3 criteria:
radiograph evidence of HF; clinical signs
and symptoms of HF; and/or administration
of a diuretic
ventricular fibrillation, sustained
ventricular tachycardia, asystole,
electromechanical dissociation,
supraventricular tachycardia, atrial
fibrillation, sinus bradycardia, or secondor third-degree heart block, along with
administration of cardioversion, atropine,
an anti-arrhythmic, rate-slowing or
sympathomimetic drug, or a temporary
pacemaker
defined as recurrent ischemic symptoms
lasting 15 minutes or more, along with
documented electrocardiographic changes
indicative of ischemia or leading to a
referral for an additional intervention
Adapted from Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J,
Mookadam F, et al. Capability of ischemia-modified albumin to predict serious cardiac
outcomes in the short term among patients with potential acute coronary syndrome.
CMAJ 2005;172:1685-90.